ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NIPT Premaitha

9.10
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Premaitha LSE:NIPT London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.10 9.00 9.20 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Premaitha Share Discussion Threads

Showing 4551 to 4573 of 6500 messages
Chat Pages: Latest  188  187  186  185  184  183  182  181  180  179  178  177  Older
DateSubjectAuthorDiscuss
24/3/2017
10:29
First ever blood tests to diagnose cancer 'could be ready in one year'hTTp://www.independent.co.uk/life-style/health-and-families/health-news/cancer-blood-test-university-of-california-jasmine-zhou-dna-tumour-samples-computer-program-a7646956.html?amp
timojelly
24/3/2017
10:28
Our next step... First ever blood tests to diagnose cancer 'could be ready in one year'http://www.independent.co.uk/life-style/health-and-families/health-news/cancer-blood-test-university-of-california-jasmine-zhou-dna-tumour-samples-computer-program-a7646956.html?amp
timojelly
17/3/2017
19:49
Nice award nom for prem
hjb1
17/3/2017
14:09
lol some people sell on the back of that research note. Short minded people. It's in a up trend now so hold tight for the ride up and of course down sometimes as well.
thinkbig?
17/3/2017
14:02
... Mind you, it was quite a good run from third week in Feb!
small crow
17/3/2017
14:01
Answer: some folk have interpreted today's RNS a little pessimistically.
small crow
17/3/2017
13:36
why are we seeing a &% drop in the sp?
2vdm
17/3/2017
12:11
The trade that never was :

"Sizeable Late trade :

2017-03-14 17:09:06 11.75 3,189,000 ? 374,708 O"

gooosed
17/3/2017
08:31
. Litigation provision – This will have a significant influence on cashflows in the next two years, or even longer if the patent case were to go to appeal

Prudent perhaps but not inspiring confidence.

gooosed
15/3/2017
08:18
Looking at today's action I think you have the answer to last night's late trade!
mhw28865
14/3/2017
18:40
yes, a buy at that price imo.
hjb1
14/3/2017
17:41
Sizeable Late trade :

2017-03-14 17:09:06 11.75 3,189,000 ? 374,708 O

gooosed
14/3/2017
12:04
Indeed: url for the announcement:
gnnmartin
14/3/2017
07:27
Announcement by Horizon (HZD) surely relevant to us today, but I'm not sure exactly how!
small crow
08/3/2017
08:55
I hope Prem people are on the phone this morning chasing payment, it's probably a legal thing anyway..I can't see they can carry on without either paying off all their debts or at least coming to some agreement to pay.
hjb1
08/3/2017
08:14
mhw28865,

imv you summed it up...................

"I would hope so but you never know these days!"

twix386
08/3/2017
07:50
I would hope so but you never know these days!
mhw28865
08/3/2017
07:44
well their first job is to pay their debts before they do anything else.
hjb1
08/3/2017
07:29
I wonder what the chances are they will pay us what the owe when this is sorted. What do you think twix ?
mhw28865
08/3/2017
07:03
Esperite secures external financing of up to EUR 9 million to support its commercial activity and development of innovative technologies

Total investment can reach EUR 13 million upon exercise of share subscription warrants

Transaction highlights

Private placement of EUR 1 million launched today through the issuance of convertible notes with share subscription warrants attached
Maximum additional potential financing of up to EUR 8 million through similar further private placements of convertible notes with share subscription warrants attached over the next 36 months, subject to fulfilment of certain conditions
Upon the exercise of all share subscription warrants, the total investment can reach EUR 13 million
Subscription by European Select Growth Opportunities Fund, a fund managed by L1 Capital Pty Ltd.
Esperite to convene an extraordinary general meeting to present the details of the financing to its shareholders and to propose to approve the issuance of further tranches of convertible notes with share subscription warrants attached
Proceeds to be used to support Esperite's commercial activities and development of innovative technologies in the field of genetics for Genoma and regenerative medicine for Cryo-Save and Cell Factory.

twix386
07/3/2017
14:32
I give them a better chance of success since they started looking for clients outside of the markets that are contested by the patent issue/litigation.
fse
07/3/2017
08:47
Given that they have a war chest to fight the litigation with Illumina, I wonder whether the latter will back off or strike a deal. Either could be good for NIPT's future.
2vdm
06/3/2017
18:20
Interestingly these are back at the same price they started life at some 3 years ago. Given the litigation issue I suppose you could see this as some what going in the right direction again. Also I gather the NHS is still on board which cant be bad.
fse
Chat Pages: Latest  188  187  186  185  184  183  182  181  180  179  178  177  Older

Your Recent History

Delayed Upgrade Clock